NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

So let me make sure I understand H2R.
Are you saying that for the external control group that any patient lost-to-follow-up is assumed to still be alive and that some of these trials didn't even track patients to 5 years or more whereas DCVAX had very few lost-to-follow-up?
That is ultraconservative and would clearly make DCVAX not look as good. It seems like the should have plotted the min and max line showing it assuming the lost-to-follow-up's are all alive and then assuming none are still alive. They could then show both graphs. Perhaps this will be discussed in detail in the journal article. I hope so. Even with the ultraconservative approach DCVAX is still clearly much than the historical SOC.
Thanks for posting this - GLTU.